| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An emerging focus on lipids in extracellular vesicles
|
Skotland, Tore
|
|
|
159 |
C |
p. 308-321
|
artikel
|
| 2 |
Bioactive lipids, inflammation and chronic diseases
|
Leuti, Alessandro
|
|
|
159 |
C |
p. 133-169
|
artikel
|
| 3 |
Editorial board members
|
|
|
|
159 |
C |
p. ii
|
artikel
|
| 4 |
Extracellular vesicle-associated lipids in central nervous system disorders
|
Vanherle, Sam
|
|
|
159 |
C |
p. 322-331
|
artikel
|
| 5 |
Extracellular vesicles as drug delivery systems: Why and how?
|
Elsharkasy, Omnia M.
|
|
|
159 |
C |
p. 332-343
|
artikel
|
| 6 |
Fatty acid metabolism in the progression and resolution of CNS disorders
|
Bogie, Jeroen F.J.
|
|
|
159 |
C |
p. 198-213
|
artikel
|
| 7 |
Insights into incretin-based therapies for treatment of diabetic dyslipidemia
|
Stemmer, Kerstin
|
|
|
159 |
C |
p. 34-53
|
artikel
|
| 8 |
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
|
Nazir, Sumra
|
|
|
159 |
C |
p. 94-119
|
artikel
|
| 9 |
Lipid efflux mechanisms, relation to disease and potential therapeutic aspects
|
Castaño, David
|
|
|
159 |
C |
p. 54-93
|
artikel
|
| 10 |
Lipid in the midst of metabolic remodeling – Therapeutic implications for the failing heart
|
Nguyen, T. Dung
|
|
|
159 |
C |
p. 120-132
|
artikel
|
| 11 |
Lipid nanoparticle technology for therapeutic gene regulation in the liver
|
Witzigmann, Dominik
|
|
|
159 |
C |
p. 344-363
|
artikel
|
| 12 |
“Lipidomics”: Mass spectrometric and chemometric analyses of lipids
|
Wu, Zhuojun
|
|
|
159 |
C |
p. 294-307
|
artikel
|
| 13 |
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
|
Butler, Lisa M.
|
|
|
159 |
C |
p. 245-293
|
artikel
|
| 14 |
Lipids in disease pathology, diagnosis & therapy
|
Lammers, Twan
|
|
|
159 |
C |
p. 1-3
|
artikel
|
| 15 |
Lipoprotein-based drug delivery
|
Busatto, Sara
|
|
|
159 |
C |
p. 377-390
|
artikel
|
| 16 |
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
|
Soppert, Josefin
|
|
|
159 |
C |
p. 4-33
|
artikel
|
| 17 |
Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy
|
Kim, Alexander S.
|
|
|
159 |
C |
p. 170-179
|
artikel
|
| 18 |
Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods
|
van Kruining, Daan
|
|
|
159 |
C |
p. 232-244
|
artikel
|
| 19 |
Sphingolipids in Alzheimer's disease, how can we target them?
|
Crivelli, Simone M.
|
|
|
159 |
C |
p. 214-231
|
artikel
|
| 20 |
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
|
Veiga, Nuphar
|
|
|
159 |
C |
p. 364-376
|
artikel
|
| 21 |
The hepatic lipidome: From basic science to clinical translation
|
ten Hove, Marit
|
|
|
159 |
C |
p. 180-197
|
artikel
|
Tijdschrift beschrijving